Clincosm LogoSign in Get a demo

Metastatic Pancreatic Cancer

Showing 26 - 50 of 158
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

Recruiting
  • Pancreatic Adenocarcinoma Metastatic
  • +14 more
  • Boston, Massachusetts
  • +1 more
Dec 6, 2022

Metastatic Pancreatic Cancer Trial in Houston (MRTX849)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Nov 22, 2022

Quality of Life, Locally Advanced Pancreatic Carcinoma, Metastatic Pancreatic Cancer Trial (ARACOMPLEX®, )

Not yet recruiting
  • Quality of Life
  • +2 more
  • ARACOMPLEX®
  • placebo
  • (no location specified)
Nov 28, 2022

Metastatic Pancreatic Cancer, Adenocarcinoma of the Pancreas Trial in Weiden (nab-paclitaxel and gemcitabine, gemcitabine mono

Completed
  • Metastatic Pancreatic Cancer
  • Adenocarcinoma of the Pancreas
  • nab-paclitaxel and gemcitabine
  • gemcitabine mono and nab-paclitaxel and gemcitabine
  • Weiden, Germany
    Kliniken Nordoberpfalz AG, Klinikum Weiden
Nov 21, 2022

Metastatic Pancreatic Cancer Trial in Bern, Basel, Zürich (Nivolumab)

Recruiting
  • Metastatic Pancreatic Cancer
  • Bern, BE, Switzerland
  • +2 more
Nov 15, 2022

Metastatic Pancreatic Cancer Trial in Siena, Verona (IOA-289)

Recruiting
  • Metastatic Pancreatic Cancer
  • Siena, Italy
  • +1 more
Oct 17, 2022

Metastatic Pancreatic Cancer Trial in Philadelphia (FOLFIRINOX)

Recruiting
  • Metastatic Pancreatic Cancer
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Sep 26, 2022

Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Boston (Nivolumab, Ipilimumab, Radiation)

Active, not recruiting
  • Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Boston, Massachusetts
  • +2 more
Sep 7, 2022

Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)

Recruiting
  • Pancreas Cancer
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Aug 19, 2022

Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in United States (Gemcitabine combined with

Recruiting
  • Metastatic Pancreatic Cancer
  • Metastatic Pancreatic Adenocarcinoma
  • Gemcitabine combined with nab-paclitaxel
  • +4 more
  • La Jolla, California
  • +20 more
Aug 18, 2022

Cancer of Pancreas, Chemo Effect, Metastatic Pancreatic Cancer Trial in Shibin Al Kawm (Gemcitabine fluorouracil)

Completed
  • Cancer of Pancreas
  • +2 more
  • Gemcitabine fluorouracil
  • Shibīn Al Kawm, Menoufia, Egypt
    Menoufia University, Faculty of medicine
Aug 5, 2022

Metastatic Pancreatic Cancer Trial in Fairhaven, Providence (FOLFOXA)

Completed
Has Results
  • Metastatic Pancreatic Cancer
  • Fairhaven, Massachusetts
  • +1 more
Jul 27, 2022

Metastatic Pancreatic Cancer, Advanced Pancreatic Cancer Trial in Lyon (Tumor samples (archival FFPE) and blood samples)

Recruiting
  • Metastatic Pancreatic Cancer
  • Advanced Pancreatic Cancer
  • Tumor samples (archival FFPE) and blood samples
  • Lyon, France
    Centre Léon Bérard
Jul 21, 2022

Metastatic Pancreatic Cancer Trial (Olaptesed pegol)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Olaptesed pegol
  • (no location specified)
Jul 19, 2022

Metastatic Pancreatic Cancer Trial in Lyon (Niraparib)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Lyon, France
    Centre Léon Bérard
Jul 4, 2022

Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Circulating Tumor Cell Trial in Montpellier (Detection of

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Detection of circulating tumor cells expressing Axl: CTC-AXL(+)
  • Montpellier, France
    CHU Montpellier
Jul 1, 2022

Metastatic Pancreatic Cancer Trial in Seoul (TEW-7197)

Recruiting
  • Metastatic Pancreatic Cancer
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Metastatic Pancreatic Cancer Trial in United States (Nab paclitaxel, Gemcitabine, Dociparstat)

Terminated
  • Metastatic Pancreatic Cancer
  • Nab paclitaxel
  • +2 more
  • Scottsdale, Arizona
  • +15 more
Jun 2, 2022

Histologically or Cytologically Confirmed Pancreatic Cancer, Unresectable or Borderline Resectable Pancreatic Cancer, Pancreatic

Terminated
Has Results
  • Histologically or Cytologically Confirmed Pancreatic Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 19, 2022

Metastatic Pancreatic Cancer Trial (nanoliposomal irinotecan, spleen irradiation)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • nanoliposomal irinotecan
  • spleen irradiation
  • (no location specified)
May 8, 2022

Metastatic Pancreatic Cancer Trial in Montreal (Salmonella-IL2, FOLFIRINOX Alone (Historical Controls), Gemcitabine/Abraxane

Recruiting
  • Metastatic Pancreatic Cancer
  • Montreal, Quebec, Canada
    Segal Cancer Centre/ Mortimer B. Davis-Jewish General Hosptial
May 3, 2022

Analysing Tissue From Metastatic Pancreatic Cancer for Drug

Recruiting
  • Metastatic Pancreatic Cancer
  • Inditreat
  • Experimental drug
  • Vejle, Denmark
    Departmen of Oncology, Vejle Hospital
Apr 26, 2022

Metastatic Pancreatic Cancer, Locally Advanced Pancreatic Adenocarcinoma Trial in Sacramento ([68Ga]Ga DOTA-5G and [177Lu]Lu

Recruiting
  • Metastatic Pancreatic Cancer
  • Locally Advanced Pancreatic Adenocarcinoma
  • [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G.
  • Sacramento, California
    University of California Davis
Apr 21, 2022

Metastatic Pancreatic Cancer, Metastatic Biliary Tract Cancer Trial in Herlev (Nivolumab, Ipilimumab, Radiotherapy)

Active, not recruiting
  • Metastatic Pancreatic Cancer
  • Metastatic Biliary Tract Cancer
  • Herlev, Denmark
    Herlev & Gentofte Hospital
Mar 29, 2022

Pancreas Cancer, Metastatic Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Jacksonville (Modified GCN+TTF treatment)

Recruiting
  • Pancreas Cancer
  • +3 more
  • Modified GCN+TTF treatment
  • Jacksonville, Florida
    Mayo Clinic
Apr 4, 2022